abstract |
The present invention is an optically active 4-substituted 1,2,3, comprising enantiomeric selective hydrogenation of the corresponding 4-substituted 1,2-dihydroquinoline in the presence of a chiral iridium (P,N)-ligand catalyst, It relates to a method of preparing 4-tetrahydroquinoline. |